High Glucocorticoid Dose Linked to Inflammation in Rheumatoid Arthritis
Author Information
Author(s): Petrackova Anna, Horak Pavel, Savara Jakub, Skacelova Martina, Kriegova Eva
Primary Institution: Palacký University Olomouc and University Hospital, Olomouc, Czechia
Hypothesis
The study investigates the impact of high cumulative glucocorticoid doses on systemic inflammation in rheumatoid arthritis patients.
Conclusion
A high cumulative glucocorticoid dose is associated with increased levels of inflammation-related proteins and altered blood counts in patients with active rheumatoid arthritis.
Supporting Evidence
- Patients with high glucocorticoid doses had elevated serum levels in 23 inflammation-related proteins compared to those with low doses.
- Active rheumatoid arthritis patients with high glucocorticoid doses showed increased white blood cell counts and altered blood ratios.
- The study highlights the need for improved care for patients on high glucocorticoid doses due to increased systemic inflammation.
Takeaway
Patients with rheumatoid arthritis who take a lot of glucocorticoids have higher levels of inflammation in their bodies, which can make their condition worse.
Methodology
The study analyzed blood samples from 72 rheumatoid arthritis patients, measuring serum levels of 92 inflammation-related proteins and assessing disease activity using the Simple Disease Activity Index.
Limitations
The sample size is modest, limiting the ability to explore the heterogeneity of rheumatoid arthritis fully.
Participant Demographics
Median disease duration of 14 years; 72 patients with rheumatoid arthritis.
Statistical Information
P-Value
< 0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website